Lupin Somerset facility gets OAI letter from USFDA Farhat Nasim18 March 2019 9:25 AM IST"The USFDA has stated that this facility may be subject to regulatory or administrative action and that it may withhold approval of any pending...
USFDA Caution: Lupin gets OAI letter for MP plant Medical Dialogues Bureau17 March 2019 9:45 AM ISTLupin has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Mandideep (Unit 1) facility...
Lupin to lays off employees from RnD Divsion Farhat Nasim15 March 2019 6:01 PM ISTMumbai: Facing a Setback in its business turf, one the largest manufacturers of medicines in the country Lupin Ltd is taking steps to rationalize its...
Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol Farhat Nasim8 March 2019 9:45 AM ISTAtorvastatin Calcium tablets are indicated to lower cholesterol in blood for adults and children over 10 years of age, Lupin said. It works by...
Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets Farhat Nasim6 March 2019 9:30 AM ISTImatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
Lupin launches Minocycline Hydrochloride extended release tablets in US Farhat Nasim27 Feb 2019 9:40 AM ISTThe company has launched Minocycline Hydrochloride extended-release tablets USP in the strength of 55 mg, after receiving approval from the United...
Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation Farhat Nasim26 Feb 2019 9:50 AM ISTThe company has received approval from the US Food and Drug Administration (USFDA) to market Methylprednisolone tablets, a generic version of...
Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30 Meghna A Singhania23 Feb 2019 12:57 PM ISTThe high court has now ruled in favour of Lupin and quashed the apex court's decision to ban Lupin's anti-diabetic drug- Gluconorm P 30.New Delhi: In...
NPPA fixes retail price of Emcure pharma's HIV drug Meghna A Singhania17 Feb 2019 9:30 AM ISTNew Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril Farhat Nasim7 Feb 2019 2:23 PM ISTLupin had a net loss of 1.52 billion rupees compared to a profit of 2.22 billion rupees in the same quarter last year, the company said.Mumbai: A...
NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details Farhat Nasim30 Jan 2019 11:32 AM ISTThe NPPA order is likely to affect various drug majors including Lupin, Sun Pharmaceuticals, GlaxoSmithKline and Cadila Pharmaceuticals. New Delhi:...
Lupin gets USFDA nod for generic schizophrenia drug Medical Dialogues Bureau8 Jan 2019 12:10 PM ISTNew Delhi: Drug maker Lupin Monday said it has received approval from the US health regulator to market Lurasidone Hydrochloride tablets, used in the...
